Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole for Refractory Invasive Fungal Infections
NCT00033982Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of posaconazole in invasive fungal infection (IFI), sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2002; status: completed.
02
Drugs
posaconazole
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00033982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033982.